Widely read:
Adobe Stock
Lupin’s share price is showing signs of strength, and the market's taking notice. The pharma stock jumped over 2 per cent today (August 7, 2025), reacting to a strong Q1 performance and growing optimism around global demand.
But as the dust settles, here’s the real question: Is Lupin gearing up for a sustained run, or is this just a short-term sugar rush?
Q1 FY26 results snapshot
Here’s how the June quarter numbers stack up:
|
Metric
|
Q1 FY26 | Q1 FY25 | YoY change |
| Revenue (Rs crore) | 4,945 | 4,330 | 14.2 per cent |
| EBITDA (Rs crore) | 1,092 | 781 | 39.8 per cent |
| EBITDA margin (%) | 22.1 | 18 | 410 bps |
| Net profit (Rs crore) | 1,221 | 805 | 51.7 per cent |
| EPS (Rs) | 26.9 | 17.8 | 51.1 per cent |
Is this a buying opportunity?
The profit bump is real, margins are expanding, and the US business is finally pulling weight again. Still, this is a space known for regulatory speed bumps and sudden setbacks.
For long-term investors, Lupin may be worth watching, not for a quick trade, but as a potential compounder if earnings continue to deliver.
About the company
Lupin Limited is a major player in the Indian pharmaceutical industry, with a global footprint in over 100 countries. It’s best known for its generics, complex generics, biosimilars and APIs. The US and Indian markets are its biggest growth drivers, and recent regulatory tailwinds in the US have given the stock some extra mileage.
Before you rush in…
Rallies like today’s often trigger FOMO. But investing isn’t about reacting to one good quarter, it’s about stacking consistent performers in your portfolio.
If you’re looking to build wealth by investing in high-quality businesses with sound fundamentals and long-term potential, our Value Research Stock Advisor service can help you identify companies like Lupin—before the market wakes up to their potential.
Disclaimer: This article was crafted with the aid of artificial intelligence and meticulously reviewed and edited by our human experts to ensure accuracy and provide valuable insights. It’s intended for informational purposes only. We encourage you to conduct your own thorough research before making any investment decisions.
Ask Value Research 
New episodes every Friday 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
